BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28102234)

  • 21. Drugs for treatment of chronic heart failure.
    Treat Guidel Med Lett; 2009 Jul; 7(83):53-6. PubMed ID: 19556942
    [No Abstract]   [Full Text] [Related]  

  • 22. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Pharmacological Therapies in Heart Failure Patients.
    Muiesan ML; Paini A; Agabiti Rosei C; Bertacchini F; Stassaldi D; Salvetti M
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):107-114. PubMed ID: 28349441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QishenYiqi Dripping Pill Improves Heart Failure by Up-Regulation of β2-Adrenergic Receptor Expression.
    Sun J; Qian H; Li X; Tang X
    J Heart Valve Dis; 2017 Mar; 26(2):193-199. PubMed ID: 28820549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registry.
    Allen LA; Tang F; Jones P; Breeding T; Ponirakis A; Turner SJ
    BMC Cardiovasc Disord; 2018 May; 18(1):80. PubMed ID: 29724164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial.
    Park K; Park TH
    Trials; 2016 Nov; 17(1):530. PubMed ID: 27809882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
    Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
    J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical use of Nebivolol in the treatment of chronic heart failure.
    Liberopoulos EN; Elisaf MS
    Hellenic J Cardiol; 2005; 46(3):208-11. PubMed ID: 15981556
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic approaches affecting diastolic ventricular function.
    Warren SE; Grossman W
    Herz; 1991 Feb; 16(1):33-45. PubMed ID: 2026382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
    Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
    Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
    MMW Fortschr Med; 2003 Jun; 145(25):56. PubMed ID: 12891860
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice.
    Biglane JB; Becnel MF; Ventura HO; Krim SR
    Prog Cardiovasc Dis; 2017; 60(2):187-197. PubMed ID: 28847619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuregulin-1/ErbB signaling and chronic heart failure.
    Xu Y; Li X; Liu X; Zhou M
    Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of congestive heart failure. Has the time come for decreased complexity?
    Rydén L; Remme WJ
    Eur Heart J; 1999 Jun; 20(12):867-71. PubMed ID: 10329091
    [No Abstract]   [Full Text] [Related]  

  • 37. Thiamine supplementation for the treatment of heart failure: a review of the literature.
    DiNicolantonio JJ; Niazi AK; Lavie CJ; O'Keefe JH; Ventura HO
    Congest Heart Fail; 2013; 19(4):214-22. PubMed ID: 23910704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging and heart failure.
    Hixon ME
    Prog Cardiovasc Nurs; 1994; 9(1):4-12. PubMed ID: 8058694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline in heart failure: a meta-analysis of clinical trials.
    Champion S; Lapidus N; Cherié G; Spagnoli V; Oliary J; Solal AC
    Cardiovasc Ther; 2014 Aug; 32(4):159-62. PubMed ID: 24758396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CORONA, statins, and heart failure: who lost the crown?
    Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
    Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.